Page last updated: 2024-10-29

avapro and Glomerulonephritis, Lupus

avapro has been researched along with Glomerulonephritis, Lupus in 1 studies

Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.

Research Excerpts

ExcerptRelevanceReference
"A substantial number of patients with lupus nephritis (LN) are refractory to conventional glucocorticoid (GC) treatment."5.39Successful treatment of class IV+V lupus nephritis with combination therapy of high-dose corticosteroids, tacrolimus and intravenous cyclophosphamide. ( Amano, K; Chino, K; Ito, T; Kato, H; Kondo, T; Kurasawa, T; Nagasawa, H; Nishi, E; Nishimura, K; Ogawa, H; Okuyama, A; Sakai, R; Shibata, A; Takei, H, 2013)
"A substantial number of patients with lupus nephritis (LN) are refractory to conventional glucocorticoid (GC) treatment."1.39Successful treatment of class IV+V lupus nephritis with combination therapy of high-dose corticosteroids, tacrolimus and intravenous cyclophosphamide. ( Amano, K; Chino, K; Ito, T; Kato, H; Kondo, T; Kurasawa, T; Nagasawa, H; Nishi, E; Nishimura, K; Ogawa, H; Okuyama, A; Sakai, R; Shibata, A; Takei, H, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kurasawa, T1
Nagasawa, H1
Nishi, E1
Takei, H1
Okuyama, A1
Kondo, T1
Nishimura, K1
Sakai, R1
Shibata, A1
Chino, K1
Ogawa, H1
Ito, T1
Amano, K1
Kato, H1

Other Studies

1 other study available for avapro and Glomerulonephritis, Lupus

ArticleYear
Successful treatment of class IV+V lupus nephritis with combination therapy of high-dose corticosteroids, tacrolimus and intravenous cyclophosphamide.
    Internal medicine (Tokyo, Japan), 2013, Volume: 52, Issue:10

    Topics: Adolescent; Antihypertensive Agents; Biphenyl Compounds; Cyclophosphamide; Cyclosporine; Drug Therap

2013